Delivery Order SPE2DB22D1106-SPE2DB24FEKY2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Potassium Citrate ER 10 MEQ tablets. The $1,566.27 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,375.66 by the Defense Logistics Agency (DLA) for Potassium Citrate ER 10 MEQ tablets (100-count bottles). The contract was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. The product will be performed at the company's...
- This federal contract award, with a unique identifier of SPE2DB20D1050|SPE2DB25FH46C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of Potassium Citrate ER 10 MEQ TB UU 100S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,100.74, with an ultimate completion date of January 24, 2025. The...
- This federal contract award, SPE2DX15D3306|SPE2DX23FADBC, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,045.00 firm fixed-price delivery order is for the supply of Potassium Chloride ER 8 MEQ Tablet, 500 tablets. The award has an ultimate completion date of September 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4564244664 ! POTASSIUM CL ER 20 MEQ TABLET 500S to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,824.78 firm fixed price delivery order has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, delivering the pharmaceutical products to support military treatment programs and facilities. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.67 firm fixed-price delivery order is for the supply of POTASSIUM CL 10% (20MEQ/15ML) CUP UD 15ML medical products, with a performance period ending on June 11, 2024. The contract award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $2,058.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4557842594 POTASSIUM CL ER 10 MEQ TABLET 1000S, with a completion date of July 20, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,919.28. The award is not set aside and covers the supply of Potassium CL ER 10 MEQ Tablets in 500-count packages, with a period of performance through July 14, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite...
- This federal contract award, valued at $2,866.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24FQZ54) for the supply of 4565097121 - Potassium Chloride Extended Release 20 MEQ Tablets in 500-count packages. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $2,876.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 per bottle. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through March 4, 2025. No set-aside designation was used for this award. Amerisourcebergen...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEKY2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,039.25 firm fixed price delivery order is for the supply of Potassium Citrate ER 15 MEQ Tablets, with an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division valued up to $750,000 through May 2024 to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/10/24 |